The burden of irreversible vision loss from Glaucoma continues to rise. While the disease
pathogenesis is not well understood, intraocular pressure (IOP) is the only modifiable risk …

Glaucoma is an optic neuropathy, specifically a neurodegenerative disease characterized
by loss of retinal ganglion cells (RGCs) and their axons. The pathogenesis of RGC loss in …

Glaucoma, a leading cause of irreversible blindness worldwide, is an optic neuropathy
characterized by the progressive death of retinal ganglion cells (RGCs). Elevated intraocular …

Glaucoma is a leading cause of irreversible blindness worldwide. To date, intraocular
pressure (IOP) is the only modifiable risk factor in glaucoma treatment, but even in treated …

Glaucoma is one of the principal causes of irreversible blindness worldwide. Yet, intraocular
pressure (IOP) is the main modifiable risk factor for disease progression. In the never-ending …

Glaucoma is an irreversible blinding eye disease which produces progressive retinal
ganglion cell (RGC) loss. Intraocular pressure (IOP) is currently the only modifiable risk …

Nanostructured lipid carriers (NLCs) loaded with palmitoylethanolamide (PEA) were
formulated with the aim to enhance ocular bioavailability of PEA, particularly to the back of …

Elevated eye pressure is the main risk factor for glaucoma, and intraocular pressure rises
when the balance between aqueous humor formation and outflow resistance is …

Current treatment strategies for glaucoma are limited to halting disease progression and do
not restore lost visual function. Intraocular pressure is the main risk factor for glaucoma, and …

Inflammation as well as glutamate excitotoxicity have been proposed to participate in the
propagation of autism. Palmitoylethanolamide (PEA) is an endocannabinoid proven to …